Literature DB >> 22760514

A rationale for multidisciplinary care in treating neuroendocrine tumours.

David C Metz1, Junsung Choi, Jonathan Strosberg, Anthony P Heaney, Colin W Howden, David Klimstra, James C Yao.   

Abstract

PURPOSE OF REVIEW: Disease heterogeneity and multisystem complications represent challenges to the diagnosis and management of neuroendocrine tumours (NET), with the disease often remaining undiagnosed for years after initial presentation. The purpose of this review is to assess the limitations of traditional care models and review the potential benefits of the multidisciplinary team approach in cancer treatment and to explore the potential usefulness of the multidisciplinary team approach for patients with NET. RECENT
FINDINGS: This article outlines important considerations for the multidisciplinary management of NET, offers a model for team structure and function and identifies skill sets of members that may augment patient care. We believe a multidisciplinary team should include three to four clinicians with extensive NET experience. A coordinating physician plays a crucial role by facilitating team cohesiveness and maintaining constant patient contact throughout the course of treatment. Our model emphasizes collaboration between members of the core team and can be extended to include interactions with community healthcare professionals and others.
SUMMARY: A multidisciplinary approach offers the best prospect for improving clinical outcomes and understanding the natural history of NET.

Entities:  

Mesh:

Year:  2012        PMID: 22760514     DOI: 10.1097/MED.0b013e32835570f1

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  11 in total

1.  Multidisciplinary sleep centers: strategies to improve care of sleep disorders patients.

Authors:  Anita Valanju Shelgikar; Jeffrey S Durmer; Karen E Joynt; Eric J Olson; Heidi Riney; Paul Valentine
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

2.  Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor.

Authors:  Gianluca Tamagno; Kieran Sheahan; Stephen J Skehan; Justin G Geoghegan; David Fennelly; Conor D Collins; Donal Maguire; Oscar Traynor; David P Brophy; Colin Cantwell; Niall Swan; Lisa McGowan; Dermot O'Toole; Donal O'Shea
Journal:  Endocrine       Date:  2013-03-08       Impact factor: 3.633

Review 3.  Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations.

Authors:  Edward M Wolin
Journal:  Oncologist       Date:  2015-08-25

4.  Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franco Grimaldi; Nicola Fazio; Roberto Attanasio; Andrea Frasoldati; Enrico Papini; Francesco Angelini; Roberto Baldelli; Debora Berretti; Sara Bianchetti; Giancarlo Bizzarri; Marco Caputo; Roberto Castello; Nadia Cremonini; Anna Crescenzi; Maria Vittoria Davì; Angela Valentina D'Elia; Antongiulio Faggiano; Stefano Pizzolitto; Annibale Versari; Michele Zini; Guido Rindi; Kjell Oberg
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

5.  Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.

Authors:  Doris T Chan; Andrea O Y Luk; W Y So; Alice P S Kong; Francis C C Chow; Ronald C W Ma; Anthony W I Lo
Journal:  BMC Endocr Disord       Date:  2016-02-24       Impact factor: 2.763

6.  Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.

Authors:  Simron Singh; Dan Granberg; Edward Wolin; Richard Warner; Maia Sissons; Teodora Kolarova; Grace Goldstein; Marianne Pavel; Kjell Öberg; John Leyden
Journal:  J Glob Oncol       Date:  2016-06-08

7.  Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.

Authors:  Edward M Wolin; John Leyden; Grace Goldstein; Teodora Kolarova; Ron Hollander; Richard R P Warner
Journal:  Pancreas       Date:  2017 May/Jun       Impact factor: 3.327

Review 8.  Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide.

Authors:  Beata Kos-Kudła; Jarosław Ćwikła; Marek Ruchała; Alicja Hubalewska-Dydejczyk; Barbara Jarzab; Jolanta Krajewska; Grzegorz Kamiński
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

9.  Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases.

Authors:  John F Tierney; Jennifer Poirier; Sitaram Chivukula; Sam G Pappas; Martin Hertl; Erik Schadde; Xavier Keutgen
Journal:  Int J Endocrinol       Date:  2019-03-12       Impact factor: 3.257

Review 10.  Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.

Authors:  Diletta Calabrò; Giulia Argalia; Valentina Ambrosini
Journal:  Diagnostics (Basel)       Date:  2020-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.